Kevin Michael O'Neill - Mar 1, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, PDx
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Mar 1, 2023
Transactions value $
-$155,823
Form type
4
Date filed
3/3/2023, 06:52 PM
Previous filing
Dec 29, 2023
Next filing
Aug 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +3.65K +14.74% $0.00 28.4K Mar 1, 2023 Direct F1, F2
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$98.6K -1.31K -4.6% $75.30 27.1K Mar 1, 2023 Direct F3
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$57.3K -763 -2.81% $75.04 26.4K Mar 2, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +10.2K $0.00 10.2K Mar 1, 2023 Common Stock, par value $0.01 per share 10.2K $75.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.